0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-2036.75%PremiumAug 16, 2024Expiry Date7.15Intrinsic Value100Multiplier19DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.05Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Renalytix Stock Discussion
Renalytix plc, a leading artificial intelligence-enabled in vitro diagnostics company, has announced an exciting new collaboration with the Steno Diabetes Center in Copenhagen. This partnership aims to advance precision medicine solutions for patients suffering from diabetes and chronic kidney disease ...
?????????????????????
No comment yet